Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from AC Immune SA ( (ACIU) ).
On June 19, 2025, AC Immune SA held its Annual General Meeting of Shareholders, where key agenda items were approved, including the 2024 financial statements, compensation reports, and re-elections of board members. The shareholders also approved financial appropriations, such as increasing accumulated losses to CHF 356,846K and setting maximum compensation for directors and executives for 2025-2026. These decisions reflect the company’s strategic direction and financial planning, impacting its operational stability and stakeholder confidence.
The most recent analyst rating on (ACIU) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on AC Immune SA stock, see the ACIU Stock Forecast page.
Spark’s Take on ACIU Stock
According to Spark, TipRanks’ AI Analyst, ACIU is a Neutral.
AC Immune SA’s overall stock score reflects mixed financial performance and technical analysis. While the company shows potential with revenue growth and a stable balance sheet, the lack of profitability and negative valuation metrics weigh heavily. Technical indicators provide some positive outlook, but the stock’s position below long-term moving averages suggests caution.
To see Spark’s full report on ACIU stock, click here.
More about AC Immune SA
AC Immune SA is a Swiss-based company specializing in precision medicine for neurodegenerative diseases. The company is known for its pioneering work in targeted therapeutics, particularly in active immunotherapy and diagnostics for conditions like Alzheimer’s and Parkinson’s diseases. With a diverse pipeline of wholly-owned assets and strategic partnerships, AC Immune focuses on developing innovative treatments and diagnostics, leveraging its proprietary technology platforms.
Average Trading Volume: 149,614
Technical Sentiment Signal: Sell
Current Market Cap: $195.9M
See more data about ACIU stock on TipRanks’ Stock Analysis page.